Sirios Capital Management L P Buys 35,947 Shares of Tenet Healthcare Corporation $THC

Sirios Capital Management L P lifted its stake in Tenet Healthcare Corporation (NYSE:THC) by 100.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 71,566 shares of the company’s stock after acquiring an additional 35,947 shares during the period. Tenet Healthcare accounts for 1.9% of Sirios Capital Management L P’s portfolio, making the stock its 18th largest position. Sirios Capital Management L P owned 0.08% of Tenet Healthcare worth $14,531,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in THC. William B. Walkup & Associates Inc. acquired a new stake in Tenet Healthcare in the third quarter valued at approximately $32,000. Canada Pension Plan Investment Board purchased a new stake in shares of Tenet Healthcare during the 2nd quarter valued at $35,000. Westside Investment Management Inc. boosted its position in shares of Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after purchasing an additional 96 shares in the last quarter. Trust Co. of Vermont acquired a new stake in Tenet Healthcare in the third quarter worth about $41,000. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Tenet Healthcare by 50.9% during the second quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock valued at $46,000 after acquiring an additional 89 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 24,000 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the completion of the transaction, the executive vice president owned 8,012 shares of the company’s stock, valued at $1,875,128.48. This represents a 74.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 48,695 shares of company stock worth $11,373,201 in the last quarter. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Trading Up 1.4%

Shares of THC stock opened at $227.79 on Friday. The stock has a 50 day simple moving average of $213.46 and a 200-day simple moving average of $203.99. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $247.21. The company has a market cap of $19.81 billion, a price-to-earnings ratio of 14.71, a PEG ratio of 1.11 and a beta of 1.39. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, equities research analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently commented on THC. Royal Bank Of Canada lifted their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a research note on Thursday, February 12th. Mizuho upped their price target on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a research note on Thursday. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday, March 1st. Finally, UBS Group increased their price target on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $250.56.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.